We studied physiological parameters of rhesus monkeys after administration of anthracycline antibiotic doxorubicin. Intravenous administration of the drug caused intoxication manifested in in an abrupt body weight loss, baldness, vomiting, and exicosis. Intoxication in monkeys determined by the damaging effects of doxorubicin on organs and tissues is also characterized by significant changes in the blood: leukopenia, thrombocytopenia, neutropenia, monocytopenia, lymphocytosis, and a sharp drop of CD20+ B cell content. The total protein and albumin content in the blood significantly decreased. A sharp increase in C-reactive protein was also accompanied by an increase in activity of proinflammatory cytokine IL-6. Transplantation of mesenchymal stem cells in some cases can significantly alleviate doxorubicin-induced damage to organs and maintain normal clinical status of monkeys after two injections of the drug. Late transplantation of stem cells does not have a protective effect and does not protect the animals from the damaging effects of doxorubicin. We found that the protective effect of mesenchymal stem cells depends on the dose of the drug, total number of cells, and the time of their transplantation. It should be noted that human and monkey mesenchymal stem cells produce similar regenerative effects, at least in the doxorubicin toxicity model.
Similar content being viewed by others
References
Agrba VZ, Lapin BA, Porkhanov VA, Konoplyannikov AG, Kal’sina SSh, Karal-ogly DD, Agumava AA, Leontyuk AV, Ignatova IE. Cultures of mesenchymal stem cells of laboratory primates and prospects of their use in experimental medicine. Stem Cells and Regenerative Medicine. Tkachuk VA, ed. Moscow, 2012. P. 23-29. Russian.
Agrba VZ, Porkhanov VA, Konoplyannikov AG, Kal’sina SSh, Karal-ogly DD, Ignatova IE, Gvozdik TE, Agumava AA, Leontiuk AV, Lapin BA. Possible aspects of using cultured stem cell of laboratory primates in experimental medicine. Bull. Exp. Biol. Med. 2012; 154(1):133-135.
Demyanov AV, Kotov AYu, Simbirtsev AS. Diagnostic value of cytokine studies in clinical practice. Tsitokiny Vospalenie. 2003; 2(3):20-35. Russian.
Dolgov V, Morozova V, Martsishevskaya R, Madrala A, Yakubovskii Z, Kabata I, Kalinovskii L, Shchepanskaya-Konkel’ M, Angel’skii S. Clinical and Diagnostic Value of Laboratory Parameters. Moscow, 1995. Russian.
Ivanov AA. Prospects of stem cells application in medicine. Stem Cell Biology and Cell Technologies. Vol. I. Pasl’tsev MA. Moscow, 2009. P. 31-43. Russian.
Lapin BA, Dzhikidze EK, Fridman EP. Guidance on Medical Primatology. Moscow, 1987. Russian.
Lapin BA, Dzhikidze EK, Shevtsova ZV, Stasilevich ZK. Simulation of Human Infectious Diseases on Laboratory Primates. Sochi, 2011. P. 225. Russian.
Maklakova IYu, Grebnev YD, Yastrebov AP. The influence of extreme factors on homing multipotent mesenchymal stromal cells. Patol. Fiziol. Eksp. Ter. 2015; 59(4):82-86. Russian.
Romanov YuA, Smirnov VN. Mesenchymal stem cells: biology and prospects of clinical application. Stem Cell Biology and Cell Technology. Vol. I. Pasl’tsev MA. Moscow, 2009: 193-205.
Simbirtsev AS. Cytokines - classification and biologic functions. Tsitokiny Vospalenie. 2004; 3(2):16-22. Russian.
Cruet-Hennequart S, Prendergast ÁM, Shaw G, Barry FP, Carty MP. Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells. Int. J. Hematol. 2012; 96(5):649-656.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent masenchymal stromal cells. The International Society for cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-317.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 1, pp. 3-9, January, 2018
Rights and permissions
About this article
Cite this article
Agrba, V.Z., Agrba, V.Z., Karal-ogly, D.D. et al. Functional Parameters of Physiological Systems of Laboratory Primates after Administration of Doxorubicin and Transplantation of Mesenchymal Stem Cells. Bull Exp Biol Med 165, 115–120 (2018). https://doi.org/10.1007/s10517-018-4111-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4111-0